In the recent video with Barrie, he said the first test they are looking to release is already in the lab, but take it to the point of care. As LDX has the rights to all these tests and have likely developed another next gen version to sell in market. They will likely leverage the current Febridx partners in HS, Thermo Fisher and other smaller distributors to get these products out there.
I would be asking closely to this if at the investor session to determine exactly what the Binx relationship is and what it means for Lumos.
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)